Michael Marner
Impact in
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
- Biotechnology top 10%
- Marine Sponges and Natural Products
Papers in
- Pharmacology 17
- Microbial Natural Products and Biosynthesis 17
- Genetics 5
- Venomous Animal Envenomation and Studies 4
- Co-authors
- Till F. Schäberle (25 shared papers)Andreas Vilcinskas (13 shared papers)Maria A. Patras (9 shared papers)Nils Böhringer (5 shared papers)Peter Hammann (7 shared papers)Zerlina G. Wuisan (4 shared papers)Michael E. Kurz (6 shared papers)Jens Glaeser (4 shared papers)
- Journals
- Microbiology Spectrum (4 papers)Marine Drugs (4 papers)Journal of Natural Products (3 papers)ChemBioChem (2 papers)RSC Medicinal Chemistry (1 paper)
- Partner nations
- GermanyUnited StatesIndonesia
In The Last Decade
Michael Marner
24 papers receiving 350 citations
Peers
Comparison fields: 5 of 55
- Pharmacology 152
- Biotechnology 36
- Molecular Medicine 28
- Microbiology 21
- Genetics 45
Countries citing papers authored by Michael Marner
This map shows the geographic impact of Michael Marner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Marner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Marner more than expected).
Fields of papers citing papers by Michael Marner
This network shows the impact of papers produced by Michael Marner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Marner. The network helps show where Michael Marner may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Marner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 45 | |
| 2 | 2020 | 41 | |
| 3 | 2022 | 28 | |
| 4 | 2022 | 27 | |
| 5 | 2022 | 27 | |
| 6 | 2019 | 20 | |
| 7 | 2023 | 20 | |
| 8 | 2023 | 19 | |
| 9 | 2020 | 18 | |
| 10 | 2021 | 18 | |
| 11 | 2024 | 17 | |
| 12 | 2021 | 16 | |
| 13 | 2020 | 13 | |
| 14 | 2022 | 13 | |
| 15 | 2022 | 9 | |
| 16 | 2024 | 9 | |
| 17 | 2021 | 4 | |
| 18 | 2022 | 3 | |
| 19 | 2023 | 3 | |
| 20 | 2024 | 3 |
About Michael Marner
Michael Marner is a scholar working on Pharmacology, Genetics, Molecular Medicine, Biotechnology and Microbiology, having authored 27 papers that have together received 360 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (17 papers), Venomous Animal Envenomation and Studies (4 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers), Marine Sponges and Natural Products (2 papers), Antibiotic Resistance in Bacteria (2 papers), Antimicrobial Peptides and Activities (1 paper), Plant-Microbe Interactions and Immunity (1 paper) and Bacterial biofilms and quorum sensing (1 paper). The work is most often cited by research in Pharmacology (152 citations), Biotechnology (36 citations), Molecular Medicine (28 citations), Microbiology (21 citations) and Genetics (45 citations). Michael Marner has collaborated with scholars based in Germany, United States and Indonesia. Frequent co-authors include Till F. Schäberle, Andreas Vilcinskas, Maria A. Patras, Nils Böhringer, Peter Hammann, Zerlina G. Wuisan, Michael E. Kurz, Jens Glaeser, Lei Wang and Deniz Taşdemir. Their work appears in journals such as Microbiology Spectrum, Marine Drugs, Journal of Natural Products, ChemBioChem and RSC Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.